Anti-Cancer Medicine

Xovoltib 20mg Xovoltib 20mg is indicated for the first-line treatment for patients with metastatic non-small cell lung cancer(NSCLC).. DESCRIPTION : Xovoltib 20mg is a targeted therapy drug It used to treat non-small cell lung cancer (NSCLC). It may also be used to treat other cancers as part of clinical trial. Xovoltib 20mg is a type of regimen called protein kinase inhibitors. Xovoltib 20mg is a targeted therapy drug DRUG – DRUG INTERACTION : Xovoltib 20mg interaction with P-gpinhibitors (cyclosporine A, ketoconazole verapamil) with Xovoltib 20mg will increase exposure to Afatinib Xovoltib 20mg interactionwith P-gpinducers (carbamazepine, phenytoin, phenobarbital) with Xovoltib 20mg will decrease exposure to Afatinib. PRECAUTIONS : Some patients have some serious condition ,the drug will make conditions worse, the conditions like : Hepatic toxicity Interstitial lung disease (ILD) Bullous and exfoliative skin disorders diarrhae Embryo-fetal toxicity:  Xovoltib ...

PROLIA 60MG Description: Prolia 60mg belongs to novel, fully human IgG2 monoclonal antibody especially to receptor activator of nuclear factor kappa-B ligand (RANKL), restrain bone resorption markers in patients with a difference of metastatic tumors and is being examined in multiple clinical trials for the inhibition and treatment of bone metastases. Chemically, it exists of 2 heavy and 2 light chains. Each light chain contains of 215 amino acids. Each heavy chain contains of 448 amino acids with 4 intramolecular disulfides. Prolia prescribed For :  Treatment for patients having postmenopausal women with osteoporosis at high risk for fracture.  Treatment for patients having to increase bone mass in women at more risk for fracture receiving  adjuvant aromatase inhibitor therapy for breast cancer. Treatment for patients with increase bone mass in men at more risk for fracture getting androgen deprivation therapy for non-metastatic prostate cancer. Pharma...

XGEVA 120MG Xgeva 120mg  belongs to novel, fully human IgG2 monoclonal antibody especially to receptor activator of nuclear factor kappa-B ligand (RANKL), restrain bone resorption markers in patients with a difference of metastatic tumors and is being examined in multiple clinical trials for the inhibition and treatment of bone metastases. XGEVA PRESCRIBED FOR :  Treatment for patients with increase bone mass in men at more risk for fracture getting androgen deprivation therapy for non-metastatic prostate cancer. Treatment for patients having to increase bone mass in women at more risk for fracture receiving adjuvant aromatase inhibitor therapy for breast cancer. XGEVA DOSAGE:  For adult : Osteoporosis :  60mg SC (subcutaneously) once every 6 months Injection of drug should be done in upper arm, upper thigh or abdomen  Giant Cell Tumor of bone : 120mg SC, every 4 weeks with additional 120mg doses on days 8 and 15 of the 1st month treatment Inje...

Sprycel 20mg Description : Sprycel 20mg belongs to oral dual BCR/ABL and Src group of tyrosine kinase inhibitor approved for use in patients with chronic myelogenous leukaemia (CML). The main aim of Sprycel , are BCRABL, SRC, Ephrin’s and GFR. Sprycel 20mg is a prescription drug which used under the supervision of doctor. Indication : Sprycel 20mg   is indicated for the treatment of adult patients having chronic myeloid leukaemia. Sprycel 20mg is indicated for the treatment of adult patients having acute lymphoblastic leukaemia. DRUG INTERACTION :  Sprycel 20mg combination with CYP3A4 inducers will reduces Dasatinib plasma concentration. Sprycel 20mg combination with antacids will decrease Dasatinib plasma concentration. Sprycel 20mg combination with H2 antagonists/proton pump inhibitors will decrease Dasatinib plasma concentration. PRECAUTION :  Using of Sprycel will results in Tumor lysis syndrome; maintain sufficient hydration and correct ur...

PROLIA - 60MG Prolia 60mg  injection is a trade name of denosumab and which belongs to type of monoclonal antibody.This drug is classified as a “bone-modifying agent”, it works as a RANK ligand (RANKL) inhibitor.  Prolia 60mg  injection which attach and repairs only certain cells in the body and help to protect healthy cells from destroy. Indication of Prolia : Prolia 60mg  injection is indicated for the treatment of Osteoporosis occur in and women (menopause stage) (end of menopause/ change of life), whose have severe problem of fractures increased or who failed to other medication of osteoporosis. Breast cancer in women whose taking certain treatment which make severe their risk of fractures and bone loss in men with prostate cancer. In adults and some adolescents with giant cell tumor of bone which cannot cured with surgery / surgery is not possible is treated with  Prolia 60mg  injection. PRECAUTION :  Prolia injection m...

SPRYCEL 20MG Description:  Sprycel 20mg is also contains second-generation inhibitor of the oncogenic tyrosine kinase BCR-ABL with 325-fold more potency than imatinib and is also able to inhibit imatinib-resistant BCR-ABL mutants. Sprycel 20mg is a prescription drug which used under the supervision of doctor. Indication: Sprycel 20mg is indicated for the treatment of adults with Philadelphia chromosome-positive acute lymphoblastic leukaemia with resistance or intolerance to prior therapy. Mechanism Of Action: Sprycel 20mg is also contains second-generation inhibitor of the oncogenic tyrosine kinase BCR-ABL with 325-fold more potency than imatinib and is also able to inhibit imatinib-resistant BCR-ABL mutants. Sprycel 20mg is a prescription drug which used under the supervision of doctor.   Dosage and administration: Sprycel indicated for Chronic Myeloid Leukaemia: Newly diagnosed: Used for recently diagnosed adults with Philadelphia chromosome-positive...